These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Neuroanatomical Correlates of Theory of Mind Deficit in Parkinson's Disease: A Multimodal Imaging Study. Díez-Cirarda M; Ojeda N; Peña J; Cabrera-Zubizarreta A; Gómez-Beldarrain MÁ; Gómez-Esteban JC; Ibarretxe-Bilbao N PLoS One; 2015; 10(11):e0142234. PubMed ID: 26559669 [TBL] [Abstract][Full Text] [Related]
8. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? Duncan GW; Firbank MJ; Yarnall AJ; Khoo TK; Brooks DJ; Barker RA; Burn DJ; O'Brien JT Mov Disord; 2016 Jan; 31(1):103-10. PubMed ID: 26202802 [TBL] [Abstract][Full Text] [Related]
9. Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson's disease. Inguanzo A; Sala-Llonch R; Segura B; Erostarbe H; Abos A; Campabadal A; Uribe C; Baggio HC; Compta Y; Marti MJ; Valldeoriola F; Bargallo N; Junque C Parkinsonism Relat Disord; 2021 Jan; 82():16-23. PubMed ID: 33227683 [TBL] [Abstract][Full Text] [Related]
10. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology. Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894 [TBL] [Abstract][Full Text] [Related]
13. Functional and structural changes in gray matter of parkinson's disease patients with mild cognitive impairment. Chen B; Wang S; Sun W; Shang X; Liu H; Liu G; Gao J; Fan G Eur J Radiol; 2017 Aug; 93():16-23. PubMed ID: 28668411 [TBL] [Abstract][Full Text] [Related]
14. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease. Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681 [TBL] [Abstract][Full Text] [Related]
15. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition. Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799 [TBL] [Abstract][Full Text] [Related]
16. Assessment of White Matter Lesions in Parkinson's Disease: Voxel-based Analysis and Tract-based Spatial Statistics Analysis of Parkinson's Disease with Mild Cognitive Impairment. Pu W; Shen X; Huang M; Li Z; Zeng X; Wang R; Shen G; Yu H Curr Neurovasc Res; 2020; 17(4):480-486. PubMed ID: 32875986 [TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease. Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368 [TBL] [Abstract][Full Text] [Related]
18. Changes of brain resting state functional connectivity predict the persistence of cognitive rehabilitation effects in patients with multiple sclerosis. Parisi L; Rocca MA; Mattioli F; Copetti M; Capra R; Valsasina P; Stampatori C; Filippi M Mult Scler; 2014 May; 20(6):686-94. PubMed ID: 24072724 [TBL] [Abstract][Full Text] [Related]
19. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease. Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897 [TBL] [Abstract][Full Text] [Related]
20. Statistically Defined Parkinson's Disease Executive and Memory Cognitive Phenotypes: Demographic, Behavioral, and Structural Neuroimaging Comparisons. Crowley SJ; Banan G; Amin M; Tanner JJ; Hizel L; Nguyen P; Brumback B; Rodriguez K; McFarland N; Bowers D; Ding M; Mareci TA; Price CC J Parkinsons Dis; 2021; 11(1):283-297. PubMed ID: 33216042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]